In our present study, the expression of DSN1 was significantly up-regulated in CRC cells and clinical tissue samples and indicated poor prognosis in CRC patients, suggesting that DSN1 contributes to maintaining the malignant phenotype of CRC. The gene discussed is DSN1; the disease is colorectal carcinoma.